The GV and WuXi AppTec-backed operator of remote laboratory manager has secured $56.1m of new funding from investors including Eli Lilly.
Pharmaceutical firm Eli Lilly participated in a $56.1m series B round for Strateos, a US-based operator of remotely controlled laboratory facilities, on Tuesday. The round was co-led by venture capital firms DCVC and Lux Capital and included Ally Bridge Group, Black Diamond Ventures, Mack & Co and Castor Ventures. Strateos has built two automated laboratory…
This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.